يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Kevin J. Kerlin"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 1
    RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

    المؤلفون: Kathryn Winter, Amit Shah, Eric A. Strom, Kevin J. Kerlin, Eileen Rakovitch, Alan C. Hartford, Barbara L. Smith, Jennifer Moughan, Eleanor M. Walker, Laura A. Vallow, Clifford A. Hudis, William Small, Albert Yuen, Isabelle Germain, Afshin Rashtian, Beryl McCormick, Anthony T. Pu, Henry Mark Kuerer, Nour Sneige, Jeannette L. Wilcox, Julia White

    المصدر: Journal of Clinical Oncology. 33:709-715

    مصطلحات موضوعية: Adult, Canada, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Urology, Breast Neoplasms, Kaplan-Meier Estimate, Mastectomy, Segmental, Risk Assessment, Disease-Free Survival, Breast cancer, Odds Ratio, Carcinoma, Humans, Medicine, Cumulative incidence, Prospective Studies, Watchful Waiting, Prospective cohort study, Aged, business.industry, Hazard ratio, Disease Management, ORIGINAL REPORTS, Middle Aged, Ductal carcinoma, medicine.disease, United States, Surgery, Radiation therapy, Carcinoma, Intraductal, Noninfiltrating, Treatment Outcome, Oncology, Female, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, business, Mastectomy, Mammography

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fd5b4544a160345bc6b0caaa3069fb
    https://doi.org/10.1200/jco.2014.57.9029

    أضف إلى المفضلة
  2. 2
    Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    المؤلفون: Anthony L. Zietman, Niall M. Heney, Stephanie L. Pugh, David J. Grignon, William U. Shipley, Howard M. Sandler, James J. Dignam, Richard Dana Lovett, Seth A. Rosenthal, Oliver Sartor, Kenneth L. Zeitzer, W. Seiferheld, Pierre Major, Felix Y. Feng, H. Lukka, Maltibehn P. Patel, Colleen A. Lawton, Luis Souhami, Kevin J. Kerlin, Thomas M. Pisansky, Alexander Balogh, Jean Paul Bahary

    المصدر: The New England journal of medicine. 376(5)

    مصطلحات موضوعية: Male, medicine.medical_specialty, Bicalutamide, medicine.medical_treatment, 030232 urology & nephrology, Urology, Kaplan-Meier Estimate, Article, Tosyl Compounds, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Prostate, Nitriles, medicine, Combined Modality Therapy, Humans, Anilides, Antiandrogen Therapy, Neoplasm Metastasis, Survival rate, Aged, Neoplasm Staging, Aged, 80 and over, Prostatectomy, Radiotherapy, business.industry, Incidence, Prostatic Neoplasms, Androgen Antagonists, General Medicine, Middle Aged, Surgery, Radiation therapy, Survival Rate, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Gynecomastia, Lymphadenectomy, Neoplasm Recurrence, Local, business, medicine.drug, Follow-Up Studies

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206fe94b5422d55bf5155658e9506d9f
    https://pubmed.ncbi.nlm.nih.gov/28854468

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  3. 3
    Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02

    المؤلفون: Mark L. Sobczak, Jeff M. Michalski, Kevin J. Kerlin, Sucha O. Asbell, Raghu Rajan, K. Bae, Howard M. Sandler, Seth A. Rosenthal, Kenneth J. Pienta

    المصدر: International Journal of Radiation Oncology*Biology*Physics. 73:672-678

    مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Paclitaxel, medicine.medical_treatment, Androgen suppression, Drug Administration Schedule, Prostate cancer, Thromboembolism, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, Etoposide, Aged, Aged, 80 and over, Chemotherapy, Radiation, business.industry, Standard treatment, Prostatic Neoplasms, Androgen Antagonists, Middle Aged, medicine.disease, Combined Modality Therapy, Radiation therapy, Leukemia, Myeloid, Acute, Chemotherapy, Adjuvant, Myelodysplastic Syndromes, Toxicity, Estramustine, business, Follow-Up Studies, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::308a448bf08ca2761e126b7e0bf5f284
    https://doi.org/10.1016/j.ijrobp.2008.05.020

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  4. 4
    A Phase III trial of 2 Years of Androgen Suppression (AS) and Radiation Therapy (RT) with or without Adjuvant Chemotherapy (CT) for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group (RTOG) Phase III Randomized Trial NRG Oncology RTOG 9902

    المؤلفون: Harold Kim, William U. Shipley, Seth A. Rosenthal, Daniel Hunt, Marvin Rotman, Jeff M. Michalski, A. Oliver Sartor, Daniel A. Hamstra, Deborah A. Kuban, Jennifer Moughan, Kevin J. Kerlin, David J. Grignon, Raghu Rajan, Howard M. Sandler, Kenneth L. Zeitzer, Viroon Donavanik, Michael C. Dobelbower, Leonard G. Gomella, Alan C. Hartford, Christopher U. Jones, Kenneth J. Pienta, Michael I. Seider

    مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Time Factors, Antineoplastic Agents, Hormonal, Paclitaxel, medicine.medical_treatment, Androgen suppression, Article, law.invention, Prostate cancer, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, Aged, Etoposide, Aged, 80 and over, Radiation, business.industry, Standard treatment, Prostatic Neoplasms, Androgen Antagonists, Combination chemotherapy, Middle Aged, Prostate-Specific Antigen, medicine.disease, Combined Modality Therapy, Radiation therapy, Tolerability, Chemotherapy, Adjuvant, Early Termination of Clinical Trials, Disease Progression, Estramustine, Neoplasm Grading, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f7d1dbad13794798d37884c59ca4ae4
    https://europepmc.org/articles/PMC4719152/

    أضف إلى المفضلة
  5. 5
    A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)

    المؤلفون: Alan C. Hartford, Howard A. Fine, W. K. Alfred Yung, Ivo Tremont, Ray S. Richards, Minesh P. Mehta, Bernadine Donahue, Meihua Wang, Walter J. Curran, Brian M. Alexander, Kevin J. Kerlin

    المصدر: Journal of neuro-oncology. 111(1)

    مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, medicine.medical_treatment, Phases of clinical research, Angiogenesis Inhibitors, Young Adult, Internal medicine, medicine, Humans, Adverse effect, Survival rate, business.industry, Brain Neoplasms, Hazard ratio, Radiotherapy Dosage, Chemoradiotherapy, Middle Aged, medicine.disease, Prognosis, Surgery, Thalidomide, Radiation therapy, Survival Rate, Venous thrombosis, Neurology, Female, Neurology (clinical), Neoplasm Recurrence, Local, business, Glioblastoma, medicine.drug, Follow-Up Studies

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a176a5f6a1c56d90967d367a8bc1d6cc
    https://pubmed.ncbi.nlm.nih.gov/23086432

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  6. 6
    NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA

    المؤلفون: Pierre Major, Himu Lukka, Niall M. Heney, Colleen A. Lawton, Alexander Balogh, Malti Patel, Oliver Sartor, Felix Y. Feng, Richard Dana Lovett, Thomas M. Pisansky, Jean-Paul Bahary, Luis Souhami, Seth A. Rosenthal, Kenneth L. Zeitzer, Howard M. Sandler, D. Grignon, Anthony L. Zietman, Kevin J. Kerlin, Stephanie L. Pugh, William U. Shipley

    المصدر: Journal of Clinical Oncology. 34:3-3

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bicalutamide, business.industry, Prostatectomy, Mortality rate, medicine.medical_treatment, 030232 urology & nephrology, Anti-Androgen, medicine.disease, Placebo, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Median follow-up, 030220 oncology & carcinogenesis, Statistical significance, Internal medicine, Medicine, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::07033da00493e486b14cb7f5ac59832d
    https://doi.org/10.1200/jco.2016.34.2_suppl.3

    أضف إلى المفضلة
  7. 7
    Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

    المؤلفون: Felix Y. Feng, Seth A. Rosenthal, H.M. Sandler, William U. Shipley, Jean-Paul Bahary, R.D. Lovett, Alexander Balogh, W. Seiferheld, Pierre Major, David J. Grignon, Kevin J. Kerlin, Oliver Sartor, Kenneth L. Zeitzer, Himu Lukka, Colleen A. Lawton, Malti Patel, Thomas M. Pisansky, Luis Souhami, Anthony L. Zietman, Niall M. Heney

    المصدر: International Journal of Radiation Oncology*Biology*Physics. 94:3

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bicalutamide, medicine.medical_treatment, 030232 urology & nephrology, Urology, Disease, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, In patient, Radiation, business.industry, Prostatectomy, medicine.disease, Elevated PSA, Clinical trial, Radiation therapy, 030220 oncology & carcinogenesis, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fcece97507440868c405bf2ce175a1a2
    https://doi.org/10.1016/j.ijrobp.2015.10.048

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  8. 8
    A phase III protocol of androgen suppression (AS) and radiation therapy (RT) versus AS and RT followed by chemotherapy with paclitaxel, estramustine, and etoposide (TEE) for localized, high-risk, prostate cancer, RTOG 9902

    المؤلفون: Raghu Rajan, H.M. Sandler, Leonard G. Gomella, Kenneth L. Zeitzer, Alan C. Hartford, Kevin J. Kerlin, Jeff M. Michalski, Seth A. Rosenthal, Daniel P. Hunt, A. O. Sartor

    المصدر: Journal of Clinical Oncology. 28:4632-4632

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, medicine.disease, Androgen suppression, Radiation therapy, Prostate cancer, chemistry.chemical_compound, Paclitaxel, chemistry, Internal medicine, medicine, Estramustine, business, Nuclear medicine, Survival rate, Etoposide, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7e342d70eb24ac9e34c88f303ec7d45d
    https://doi.org/10.1200/jco.2010.28.15_suppl.4632

    أضف إلى المفضلة
  9. 9
    Preliminary Analysis of RTOG 9902: Increased Toxicity Observed with the Use of Adjuvant Chemotherapy

    المؤلفون: Seth A. Rosenthal, Eugen B. Hug, Kevin J. Kerlin, A. Sucha, Raghu Rajan, Michelle DeSilvio, J.M. Michalski, Howard M. Sandler, Kenneth J. Pienta

    المصدر: International Journal of Radiation Oncology*Biology*Physics. 63:S123

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Radiation, Adjuvant chemotherapy, business.industry, Internal medicine, Toxicity, medicine, Radiology, Nuclear Medicine and imaging, business, Preliminary analysis

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::243e49374f89d05fac4a2137d6190404
    https://doi.org/10.1016/j.ijrobp.2005.07.209

    View record from ScienceDirect
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء